Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Research on Early Diagnosis and Risk Stratification Biomarkers of Anti-Tumor Drug-Associated Interstitial Pneumonia Driven by Multi-Omics Integration

NCT07190703 is registered in ClinicalTrials.gov with Fuzhou University Affiliated Provincial Hospital as lead sponsor.

NCT NCT07190703
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07190703 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Research on Early Diagnosis and Risk Stratification Biomarkers of Anti-Tumor Drug-Associated Interstitial Pneumonia Driven by Multi-Omics Integration
Lead sponsor
Fuzhou University Affiliated Provincial Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
September 30, 2025
Completion date
September 30, 2026
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anti-tumor drug-associated interstitial pneumonia